A therapeutic strategy targeting TLRs to improve host immunity has been utilized to treat gastrointestinal disease by applying Lactobacillus species; for example, Lactobacillus crispatus can modulate epithelial cell defense against Candida albicans through the TLR2 and TLR4 pathways (33). The gene discussed is TLR4; the disease is gastrointestinal disease.